Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.
D000293:Adolescent; D000367:Age Factors; D001344:Autopsy; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004487:Edema / Q000473:pathology; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006329:Heart Conduction System / Q000503:physiopathology; D006333:Heart Failure / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009206:Myocardium / Q000473:pathology; D009210:Myofibrils; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin